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INTRODUCTION 
 Surgical site infections (SSIs) still continue to be a significant problem for 
surgeons, which accounts for almost 40% of hospital acquired infections.  It increases 
the hospital stay thereby increasing the expenditure incurred by the patient and adds to 
the economic burden of the country. 
SSIs usually occur 5 to 6 days postoperatively, 90% of which occurs within 30 
days after surgery. The goal of surgical prophylaxis is to ensure that a satisfactory 
tissue concentration of a drug with a reasonable spectrum activity against expected 
organisms is achieved and maintained during the period of potential bacterial 
contamination of the wound. So that organisms introduced into the wound during the 
operation would be destroyed immediately. 
Failure to maintain adequate serum and tissue levels throughout the surgical 
procedure increases the likelihood of the infection. Polk and Lopez-Mayor, have 
emphasized that wounds levels, not blood or serum levels, appear to determine the 
efficacy of agents for prophylaxis of operative wound infection. These very high tissue 
levels could be achieved by a preoperative intraincisional injection. So to achieve high 
target tissue concentrations with effective antibiotic according to the microbiological 
prevalence of organisms in both clean contaminated, contaminated and dirty surgical 
incisions is the need of the hour. 
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It is not advisable to use the antibiotic for a prolonged period of time, fearing 
the emergence of multi drug resistant strains.      
                                                                                                                                                        
Undue fear in surgeons minds? 
             Surgical-site infection (SSI) rate in clean surgeries and clean contaminated 
surgeries are 2% to 5% and upto 20% respectively. Usually prophylaxis is not used for 
clean surgeries. But prevalent usage of prophylactic antibiotics in these clean 
procedures is due to the undue fear of infection in the minds of majority of our surgeons. 
Appropriate usage of antibiotics gains paramount importance due to emergence of multi 
drug resistant strains. 
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AIM OF THE STUDY 
 To compare the efficacy of preoperative ceftriaxone infiltration at the incision 
site and Intravenous antibiotic administration with that of Intravenous ceftriaxone only 
in preventing surgical site infection in all laparotomy surgeries taken in elective and 
emergency manner and measuring the drug concentration in serum and incisional tissue 
drain fluid. 
To compare the surgical site infection in two groups of patients,  
Group A -  IV ceftriaxone + Local infiltration 
Group B -  IV ceftriaxone only. 
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REVIEW OF LITERATURE 
Historical background: 
Since the dawn of time, infections are a nightmare for surgeons.  Development 
of theory of antisepsis and germ theory helped us in the understanding of wound 
infection.  The scientific development after 19th century and the contributions of 
physicians of that era improved the knowledge on pathophysiology, treatment and 
prevention of surgical site infections. Many observations made by nineteenth century 
physicians were crucial in our knowledge regarding the pathophysiology, treatment and 
prevention of surgical site infections. 
In 1846, Ignaz semmelweis, a physician in Vietnam hypothesized that puerperal 
fever was caused by a putrid material transmitted from autopsied patients. Simple 
chlorine water hand wash reduced mortality drastically but his ideas were not accepted 
at that time.  
Louis Pasteur formulated germ theory and proved that contagious diseases are 
caused by specific microbes. He pioneered techniques of sterilization and discovered 
pathogenic bacteria like Staphylococcus, Streptococcus, and pneumococcus. 
Joseph lister used  carbolic acid dressings for the amputated stump which 
drastically decreased the mortality rate by 50%.  Carbolic acid were used to treat sewage 
in his times in Europe.  Immense postoperative outcome popularized the use of this 
method all over Europe. 
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In 1880, Robert Koch, through his Anthrax experiments identified and isolated 
pathogenic organisms associated with specific disease like anthrax,cholera and 
tuberculosis. He also putforth, four postulates popularly called as ‘Kochs postulates’. 
Charles Mc Burney, pioneer in the principle of source control (i.e, surgical 
intervention to eliminate the source and thereby treat the infection) performed 
appendicectomy as treatment of appendicitis, which was previously known to be a fatal 
disease. This was popularised by Sir Frederick Treves, after performing it successfully 
on King Edward VII of England. 
              The discovery of effective antimicrobials helped the modern surgeons to treat 
wound infections in a much better way, during the twentieth century. During world war 
I, Sir Alexander Fleming, an army medical officer in British Medical Corps identified 
the first antibacterial agent Penicillin through his works on the natural action of blood 
against bacteria and sepsis. During his study on influenza virus, in 1928,  he noticed a 
zone of inhibition around a mould colony  that  grew profusely on a plate of 
Staphylococcus.  He then named the  derived substance as ‘penicillin’.  
           This marked the milestone in the development of innumerable potent 
antimicrobial agents against infectious organisms, which spread their use from 
prophylaxis to treatment of postoperative wound infections. 
         The discovery of autochthonous microflora of skin, respiratory tract, alimentary 
tract enabled the modern surgeons to widen their knowledge about specific organisms 
which will be encountered. 
6 
 
          Frank Meleny and William Altemier, brought out the fact that aerobes and 
anaerobes synergise to cause serious infection including soft tissue infections and 
intraabdominal sepsis. Hence the concept of non-pathogenic microorganisms was 
obsolete since they too caused infections on entering sterile cavity during surgery.  
Intraabdominal toxic peritoneal fluid aspirate showed the growth of both aerobes and 
anaerobes.  
     William osler, an American physician noted the host response to an organism from 
his observations that patient died due to inflammatory response in the body to a 
organism. This host inflammatory response is because of activation of multiple 
pathways in response to an infection. Exaggerated inflammatory response leads to end 
organ failure and multi organ dysfunction. Thus, the balance between treatment and side 
effect is one of the challenges face by surgeons like us. 
PATHOGENESIS OF INFECTION: 
Host defences:  
 Barrier 
 Microbial flora 
 Humoral responses 
 Cellular responses 
 Cytokine production                                   
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Defense barriers: 
• Physical barriers 
• Chemical barriers 
• Immunologic barriers 
Mammalian host possesses intrinsic defense mechanisms that help to prevent 
invasion of microbes, multiplication of organisms and thereby cause containment of 
infection. Our host defences are highly regulated system and are very effective in coping 
the invaders. They include:- 
1. Site specific defences  (SSD) 
2. Systemic defenses 
Site specific defenses provide protection at tissue level.  
Systemic defences begin immediately after invasion of pathogen into sterile area 
of body. 
Any micro organism will have to face number of barriers in the body. 
• Epithelial barrier 
• Mucosal barrier. 
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          Mucosal barriers provided by mucosa of respiratory, gastrointestinal and 
urogenital system.  
          Host barrier cells prevent invasion of microbes and  proliferation by secreting 
certain substances. Skin commensals adherent to surface preclude virulent organism 
invasion, thereby forming colonisation resistance. 
PHYSICAL BARRIERS: 
Skin: 
   Skin, the largest organ in the body provides most extensive physical barrier. 
Resident or commensal microflora on the surface of skin block the attachment of 
noncommensal microbes. Chemical secreted by sebaceous gland and shedding of the 
epithelium also provide innate immunity. Some of the endogenous microflora include 
staphylococcus, streptococcus, corynebacterium, propionibacterium species. Also, 
Enterococcus faecalis, Enterococcus faecium, Escherichiae coli, Enterobacteriacae and 
Candida albicans are isolated from skin surface below the umbilicus. Diseases of the 
skin are associated with overgrowth of skin commensals. 
Respiratory tract: 
            Host defences in respiratory tract maintains a sterile environment in the distal 
bronchi and alveoli under normal conditions. Larger particles are cleared through 
cough. Smaller particles are cleared by pulmonary macrophages through phagocytosis. 
Any defect in these host defences leads to bronchitis or pneumonia. 
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         Resident microflora are usually absent in urogenital, biliary and pancreatic ductal 
system. However, in case of inflammation, malignancy, stone formation or 
catheterisation, microorganisms may proliferate. 
Gastrointestinal tract: 
          The oropharynx and colorectal region are highly colonised by many 
microorganisms. It is because of the following reasons: 
1. Highly acidic environment in stomach kills the microbes. 
2. Decreased motility in stomach during initial phases of digestion increases the 
contact time. 
Thus, microbial population in stomach accounts to approximately 102 to 103 
colony forming units (CFU). But this may be increased during disease states or drug 
intake. 
In terminal ileum the colony count to approximates to 105 to 108 CFUs. Relatively 
static and hypoxic environment of the colon promotes florid growth of bacteria, where 
aerobic species are outnumbered by anaerobic organisms to approximately 100: 1. 
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             FIGURE 1 MICROFLORA IN GASTROINTESTINAL TRACT 
    Part of GIT Microbial population(CFU/ ML) 
Stomach 102  to 103 
Small intestine  105  to 108 
Distal colorectum 1011  to 1012 
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Along with facultative and obligate anaerobes like Bacteroides, Lactobacillus, 
Clostridium, Fusobacterium and Eubacterium, other aerobic microbes like Escherichia 
coli, Enterococcus faecalis, Enterococcus faecium, Enterobacteriacae and Candida 
albicans are also present in the colon. They provide resistance against colonisation of 
pathogens like Vibrio cholera, Shigella, Salmonella. But whenever any pathology arises 
the commensal organisms provide nidus of infection for the pathogens to proliferate. 
Surprisingly very little host organisms contribute to the intra abdominal infection.  
When pathogens try to colonise specific body compartments or tissue, defense 
mechanisms act to eliminate or remove the nidus of infection. Apart from providing 
physical barrier, certain proteins like  
1. Lactoferrin and Transferrin sequester microbial growth factor iron. 
2. Fibrinogen in inflammatory fluid trap micro organisms and polymerises to fibrin. 
3. Diaphragmatic pumping mechanism on the undersurface of diaphragm help in 
expunging micro organisms from peritoneal fluid. 
4. Omentum, ‘the policeman of abdomen’ serves to limit infection. 
Immunologic barriers:- 
Defense mechanisms in tissues of the body include ;- 
a) Resident macrophages that regulate cellular host defense. 
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b) Secretion of cytokines that is upregulated by substances like TNF – alpha, 
IL- 1 beta and INF Gamma. 
Opsonisation is the result of interaction of microbes with host defense 
mechanism.  This is followed by formation of membrane attack complex for 
extracellular destruction and  formation of phagocytic vacuoles for intracellular 
destruction of microorganisms. 
Both alternate and classical complement pathways get activated after microbial 
invasion and release complement fragment (C3a, C4a, C5a) that increases vascular 
permeability. Chemotaxis and diapedesis of neutrophils occurs within minutes and it 
peaks within a period of hours or days. This also leads to the influx of inflammatory 
transudate to the area of microbial invasion. 
Response to an infection depends upon several factors: 
1) Number of micro organisms entering the body. 
2) Proliferation of organisms 
3)  Virulence of organisms 
4) Potency of defense mechanism 
Control of microbes can either or lead to  
a) Eradication of infection 
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b) Limitation of infection ( purulent infection is the hall mark of chronic 
infection) 
c) Locoregional infection (cellulitis, soft tissue infection) 
d) Systemic infection (bacteremia) 
Infection is defined as an ‘identification of microorganisms in host tissue or 
bloodstream, plus an inflammatory response to their presence’. The hallmark of 
inflammation are ‘rubor, tumor, calor, and dolor’ , at the site of infection. The systemic 
manifestations  include tachycardia and tachypnoea, increased temperature and 
leucocytosis. Above noted systemic manifestations comprise the ‘systemic 
inflammatory response syndrome ‘(SIRS). 
 
Fig 2. Infection and SIRS 
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“Sepsis is not an antibiotic deficiency syndrome” 
SIRS when it is caused by microbial infection is termed as sepsis and it is 
mediated by production of a cascade of numerous proinflammatory mediators produced 
in response to the products of microbial invasion. These products can be a 
lipopolysaccharide (endotoxin) derived from gram-negative bacteria; or a 
peptidoglycan and teichoic acid from gram-positive bacteria; or a fungal cell wall 
component such as mannan. Patients have sepsis if they meet the following  clinical 
criteria for SIRS and have an evident local or systemic infection. 
Sepsis has several subsets within it according to the severity of infection, which 
can be severe sepsis and septic shock. 
              Severe sepsis is defined as sepsis  along with the occurence of new-onset  
failure of organs. It is the frequent cause of death in surgical intensive  care units, with 
a very high mortality rate. i.e., 
The clinical features of severe sepsis are   
• need  ventilatory support 
• unresponsive to fluid resuscitation  
• requirement of  vasopressors to correct hypotension. 
               Septic shock is a state in which patient has acute circulatory failure which is 
usually identified by  
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• Occurence of persistent  hypotension (systolic blood pressure <90 mmHg)  
• Inspite of aggressive  fluid resuscitation,  
• With no other identifiable causes. 
 It is the severe manifestation of infection. It can occur in approximately 40% of patients 
with severe sepsis; with a very high mortality rate. 
PATHOGENS OF INTEREST FOR SURGEONS: 
1. BACTERIA 
“Are bacteria infecting our world or we living in theirs?”  , remains a mysterious 
question. The bacteria have been present in this earth millions and millions of years 
before evolution of human race. Hence combating the pathogenic bacteria and 
preventing sepsis is the need of the hour 
Cell wall staining: 
• . For choosing an appropriate antibiotic, and to know if a bacteria is susceptible 
to a specific antibiotic, the gram staining property of a bacteria is important 
 This staining imparts specific colour to bacterial cell wall through which it is 
classified as gram positive and gram negative. 
a) When they stain blue, they are termed as gram-positive bacteria. 
b)  And when a bacteria stains red, it is termed as gram-negative. 
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Gram-positive bacteria  
      The bacteria that cause surgical site infections  are: 
a) skin commensals  
 Staphylococcus aureus and 
 Staphylococcus epidermidis and  
 Streptococcus pyogenes and 
When the normal intergrity of the integument is breached by a surgical incision, 
these bacteria either alone or in combination with other organisms become pathogenic. 
b) commensals of GIT such as 
     Enterococci faecalis and  
    Enterococci  faecium.  
They have the capability to cause nosocomial infections like respiratory 
infections, catheter associated infections urinary tract infections (UTIs) and 
septicaemias in immunologically compromised or chronically debilitated patients. But 
in healthy individuals, these are of little importance. 
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Gram-negative bacteria: 
The organisms which a surgeon specially interested among gram negative 
species include: 
 E. coli,  
 Proteus vulgaris and mirabilis 
 Klebsiella pneumoniae 
 Serratia marcescens 
 Pseudomonas aeruginosa,  P. fluorescens. 
 Enterobacter 
Anaerobic organism 
• Oropharynx and colorectum are colonised by anaerobic bacteria (that lacks 
catalase), also capable of producing infection in other areas of the body.   
• These organisms are not able to multiply or divide  in the presence of atmospheric 
air. 
 C. Perfringens 
 C.difficile 
 C. tetani 
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 C. Septicum or novyi. 
 Bacteroides fragilis 
 Propionibacterium  
 Fusobacterium spp. 
   Other bacteria of interest to surgeons include:  
 Mycobacterium tuberculosis 
 M. avium-intracellulare and M. Leprae. 
 Nocardia  
• These are acid fast and are very slow growing bacilli. 
• They are not easily cultivated in laboratory and need specific culture media to 
grow which may take several weeks to months. 
• They are notorious in causing severe pulmonary and extra pulmonary infections 
which is still prevalent in our country. 
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Viruses:             
• Though small in their size, they cause wide variety of infections, especially in 
immunocompromised patients.  
Viruses of specific importance for surgeons include: 
 Hepatitis viruses B and C 
 Ebstein barr virus 
 Cytomegalovirus 
 Herpes simplex virus     
 Herpes zoster virus. 
Fungi 
• They are identified by any one of the special staining methods like, KOH mount, 
Giemsa, India ink, methenamine silver. 
• These can be present in yeast form, budding forms or can be observed with 
numerous branching along with septations. 
• They can cause surgical site infections combined with bacteria. 
• They cause severe infections in immunocompromised patients. 
• Fungi of interest to surgeons include: 
20 
 
 C. albicans  
 Mucor 
 Rhizopus  
 Absidia spp 
 Cryptococcus neoformans 
 Aspergillus fumigates and A. niger, 
 Coccidioides immitis.              
                                                          
SURGICAL SITE INFECTIONS 
NOMENCLATURE 
• DEFINITIONS: 
Earlier, the term, ‘Surgical Wound Infection Task Force’ (SWITF) was used to 
ascribe surgical site infections. 
The term ‘SURGICAL WOUND’–was replaced by  ‘SURGICAL SITE 
INFECTION’. This term was formulated by CDC in 1992. 
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Figure-3  Classification of surgical site infection 
 
Figure-4   Superficial SSI 
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CATEGORIES OF SSI 
 SSI were categorized into two, 
1. Incisional SSI  
» Superficial  
» Deep 
2. Organ/space SSI. 
          Of surgical infections, 60 to 80% are incisional and the remainder are 
organ/space infections. 
SUPERFICIAL SSI 
A superficial SSI can be defined as ‘An Infection occuring within 30 days of 
surgery and it involves only the skin and subcutaneous tissue of incision’. 
It includes: 
• Purulent aspirate from the site of incision associated with or without positive 
culture 
• Local signs of infection and inflammation  –  pain, tenderness, localised 
swelling, redness, heat and this is usually followed by  
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FIGURE 5 DEEP INCISIONAL SSI 
 
 
• deliberate opening of the superficial incision by surgeon, unless the results of 
culture reports are negative. 
• Micro organisms obtained  from the culture of fluid or tissue taken aseptically 
from a superficial incision 
• Diagnosis of superficial  infection made by the surgeon 
     Conditions which should not be considered as SSI include: 
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              1.  Stitch abscess 
              2.   Episiotomy wound   
              3.  Infection at the site of circumcision in a new born child. 
               4.  Infected burn wound            
                                                                                                                                     
DEEP INCISIONAL SSI 
          Deep incisional SSI can be defined as ‘An Infection that is  occurring within 30 
days of surgery ( 1yr if an implant is in place) and infection involving deep soft tissues. 
         It usually  includes: 
• Purulent discharge from the site of  deep incision. 
• Fever of 38 degree celsius or More. 
• Local pain / tenderness at the incision site and incision dehisces spontaneously  
or is opened deliberately. 
• Abscess or other evidence of infection which involves the deep incision and 
found on direct examination / visual / radiological / histological examination. 
•    Diagnosis made by the physician / surgeon. 
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ORGAN / SPACE SSI 
         An organ or space SSI can be defined as ‘An Infection occuring  within 30 days ( 
1yr of implant ) or Infection involving any other part of the anatomy other than that of 
the incision site which was opened / manipulated at the time of surgery. 
       It  may include :  
• Purulent  aspirate from the organ / space operated which is identified by a drain 
•  Micro organisms  from the culture obtained aseptically 
•  Infection identified during reoperation / Histological  examination/ imaging. 
 
ORGAN SPACE SSI MASQUERADING INCISIONAL SSI 
        The following organ space surgical site infection pretends to be an incisional SSI. 
• Imaging studies done to rule out subfascial collection / fistula from hollow 
organs. 
• Presumptive usage of systemic antibiotics. 
• Interventional radiology/ re-operation done. 
• Trigger the lethal MOF( multi organ failure) 
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FIGURE 6 ORGAN/ SPACE SSI 
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CLASSIFICATION OF SURGICAL WOUND INFECTION: 
CLASS – I    :    Clean wound  
     (Expected wound infection rate is 1-2%) 
Definition:-          
 -    Atraumatic wound   
           -  There are no signs of  inflammation 
 -   Gastrointestinal, Respiratory, GenitoUrinary,      
Biliary tracts are not entered. 
Organisms :-- Staphylococcus aureus, Staphylococcus epidermidis  
Example:--  Hernia repair, Breast surgeries, Thyroid surgeries. 
CLASS – II :– 
         Clean contaminated 
         Expected infection rate-non colorectal surgeries- 2.1-9.5% 
Expected infection rate for colorectal surgeries- 4-14% 
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Definition :-    
Elective operation of GIT, Genito Urinary, respiratory tract    have been entered 
during surgery under controlled conditions 
Organism:--   Endogenous micro flora of the organ that has been entered 
Example:--   Cholecystectomy,  Elective bowel resection(not colorectal), colorectal 
surgeries 
CLASS – III: 
CONTAMINATED WOUNDS 
( Expected infection rate is 20-25%) 
Definition :--    
traumatic wounds(fresh) 
any  breach in the sterile technique used 
Gross spillage from Gastrointestinal tract 
Acute non purulent inflammation 
Organism  :--  Endogenous bacteria 
Example  :-  Appendicectomy  
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CLASS  - IV 
     DIRTY WOUND 
     (Expected infection rate is 30-40%) 
Definition :--  
Old traumatic wounds 
Devitalized tissue 
Gross purulence  
Pre existing infection 
Perforated viscera 
Example   :--     Perforative peritonitis, Hartmann's operation for perforated diverticulitis 
RISK FACTORS: 
•  Rate of SSI is dependent on several variables like 
1. Patient  
2. Type of surgery 
3. Perioperative environment 
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4.  Type of pathogen 
RISK of SSI =  dose of contamination   x   virulence 
host resistance 
             CDC SENIC (Study of  effect of  nosocomial infection control) describes 
about the predictive index for a surgical site infection.                   
 The  following four factors are being considered:-- 
1) An Abdominal operation 
          2) An operation that lasts longer than 2 hrs 
3) An operation that is contaminated 
4) A patient who will have three or more diagnosis at the time of discharge 
exclusive of wound infection 
The patients are given a score of 0 or 1 for the above said variables. 
NNIS risk index 
 
(National Nosocomial Infection Surveillance - and its successor program, the National 
Healthcare Safety Network (NHSN) 
NNIS- NHSN framed the following variables for risk index in surgical site infection. 
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• American Society of Anaesthesiologist score–    3 or more (chronic active 
medical illness) 
• Length of operation    –    > 75th  percentile of its duration  to a particular surgery
                  
• Level of contamination  –    contaminated/ dirty 
The risk factors associated with surgical site infection can be: 
I. PATIENT FACTORS 
II. ENVIRONMENTAL FACTORS 
III. TREATMENT FACTORS 
PATIENT FACTORS 
This includes: 
1. Ascites/chronic inflammation  
2. Obesity / undernutrition 
3. Diabetes / hypercholesterolemia / PAOD / immunosuppression 
4. Hypoxia/ postop anaemia/ recent operation/ remote infection 
5. Extremes of age 
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ENVIRONMENTAL FACTORS: 
• Contaminated medication 
• Inadequate disinfection or sterilisation 
• Inadequate antisepsis 
• Inadequate ventilation 
• Presence of foreign body 
TREATMENT FACTORS: 
• Drain  
• Emergency procedure 
• Inadequate antibiotic coverage 
• Preoperative hospitalisation 
• Prolonged operation 
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SURGICAL WOUND SITE SURVEILLANCE:  
Surveillance of wound site is usually done by 
a)  sterile dressing for 24-48hrs after surgery (IB) 
b) washing hands before and after changing dressing (IB) 
c) usage of sterile technique for dressing (II) 
MEASURES TO PREVENT SSI: 
PREPARATION OF PATIENT : 
               Before preparing the patient for an elective operation, the following steps must 
be undertaken.  
  Identify and treat infections away from the surgical site before operation. 
 Keep the pre-operative stay as short as possible 
 Proper control of blood glucose levels 
 Ask the patient to take a bath before the surgery.  
 Do not remove hair unless it interferes with operation and if required, remove 
with electric clippers immediately before operation. 
 Abstain From any forms of  tobacco or alcohol consumption  prior to operation 
 Apply antiseptic agent in concentric circles moving towards periphery. 
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PREPARATION OF THE OPERATING TEAM 
1. Nails should be kept clean and  short   
2. Surgeon should not wear any rings or hand jewellery 
3. Preoperative surgical scrub for 5 minutes 
4. Scrub the hands till elbows for a surgical hand washing 
5. Water should always flow from hands towards elbow after a scrub 
  6.  Always use a  towel,  gown and gloves which is sterile 
Principles of prophylaxis: 
           Use of multiple methods (physical, chemical, and antimicrobial therapies) or a 
combination of these to decrease the presence of exogenous factors (surgeon and 
operating room environment) and endogenous factors (microorganisms) is called 
prophylaxis.   
Effective Source control: 
            The primary concept in the treatment of surgical site infections includes: 

 drainage of pus  

 wound débridement including infected and devitalized tissue  

 extrusion of foreign bodies  
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
 treatment of the  root cause of infection. 
Prophylactic antibiotic treatment  
          The usage of empirical antibiotics before a surgery or  during  and sometimes 
even after a surgery to prevent complications of infections. 
Therapeutic antibiotic treatment  
         The usage of substances that decrease the  growth or multiplication of organisms, 
which also includes its eradication . Thus, it reduces infection caused not only by a 
pathogen but also the infection caused by the organism  which colonises a gut or skin 
of the  patient.         
Antibiotic Prophylaxis: 
        Antibiotic prophylaxis was first proposed by Miles and Burk in 1950. 
Prophylaxis should be planned so that it is administered at the time of induction 
or skin incision.  Because, 
• after 3 hrs of  entry of infectious agent, it becomes  very ineffective. 
• Concentration of organisms > 100,000 / gm of tissue usually exceed the capacity 
of host defense.  
What are the Principles behind prophylaxis 
• Always use the antibiotic agent which is likely to cause the probable infection 
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• Use full dose of any antibiotic chosen 
• Administer the chosen  drug  prophylactically  
• If duration of operation is  prolonged for more than 3 hrs, give another dose of 
the chosen antibiotic. 
• Employ post operative antibiotic, when the risk of infection is increased. 
“The consensus is that a single dose of antibiotic immediately before  an operation 
is enough and that there are dangers not only to  hospital but also to the patients in 
prolonged course of prophylactic antibiotics. 
Resistance to antibiotics is related closely to the prolificity with which antibiotics are 
prescribed” 
How to administer? 
 a) Prophylaxis must be planned such that maximum bactericidal concentration 
of the agent reaches the serum and the tissues while putting an incision on the skin.  
Timing of Antimicrobial Prophylaxis 
  According to a Prospective Observational study conducted, Consecutive 
surgical patients were studied over a 1 year period which included 3836 various 
surgeries performed. 
According to that study,   
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• When antibiotic was administered 0 to 30 minutes before incision,  P value 
was  < 0.001.  
• When the same was administered 60 to 120 minutes before incision, the 
reported  P value was equal to  0.035. 
• Hence it was concluded that it is better to give prophylaxis half an hour before 
any surgical procedure. 
Single dose prophylaxis 
 In 1977, STRACHAN and his colleagues first proposed single dose antibiotic 
prophylaxis. They proposed single dose of broad spectrum antibiotic prior to surgery 
without any usage of it after the procedure. 
Trial of single dose vs no antibiotic: 
In one of the study conducted, comparison was done between single dose of 
preoperative antibiotic (cefazolin) against  5 days of post operative treatment of the 
same. Infection rate of prophylactic group was about 3% and in the other group where 
post operative antibiotic was given the infection rate was 5%. 
Trial of Single dose vs. Multiple dose  of antibiotics:     
Comparison was done between patients undergoing Colonic surgery receiving 
single dose of prophylactic antibiotic against multiple doses of antibiotics. Out of 510 
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surgeries done in single dose group, infection rate was 4.3% and in the group of 493 
patients who received multiple doses of antibiotic, the infection rate was 6.9%. 
 Results of  27 studies conducted were as follows: 
 Single dose Multiple doses 
Operation  510   493 
Infection 22 34 
Rate of infection 4.3% 6.9% 
 
Intraincisional subcutaneous infiltration of antibiotic: 
The concept of “preincisional - intraincisional” subcutaneous infiltration 
of antibiotics directly into the wound was first reported by Taylor et al in 1982. This 
technique achieves high local concentrations of antibiotic combined with adequate 
serum levels. 
  The use of subcutaneous route for administration of antibiotics and iv 
fluids predates to 1900. However this method became obsolete in 1950 due to side 
effects like volume overload and shock. The easy practice of  intravenous access also 
added to the factor. Again in 1980, the subcutaneous route of antibiotic administration 
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gained importance , particularly in elderly persons for whom iv access was inaccessible. 
Slowly gaining its importance and its easiness of use, it again came into limelight.  
There are meta analytical studies stating that subcutaneous route can be 
safely administered and certain group of drugs to be avoided to decrease toxicity. 
Inaddition by achieving a high local concentration, the antibiotics that are 
being administered locally through subcutaneous route also gets absorbed into the 
systemic circulation and achieving its peak concentration.  
Almost 100 % bioavailability for third generation cephalosporins, has 
been observed, the peak concentration achieved is 1.5 – 2 hours post subcutaneous 
injection. Hence the time taken to achieve the peak (Tmax) is increased.  
Though Cmax maximum concentration could not be achieved early, but 
steady state equilibrium is reached after a period of time, and the concentration was well 
ahead of the MIC of most pathogenic bacteria of interest. 
Although skin reactions like skin edema, erythema, itching has been 
reported, but not for usual dose of 1g or 0.5 g.  
Other group of antibiotics like aminoglycosides, presented with poor local 
tolerance, local reactions were more and toxicity also increased by this method. With 
this scientific fact of subcutaneous injection of antibiotics,  
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Trial of subcutaneous infiltration of antibiotic vs intravenous route alone: 
Bhargava et all, states that “local infiltration of metronidazole at the 
incision site is a safe and effective measure to control wound infection in perforative 
peritonitis”cases, a study done in our country states. 
Bhushan dogra et all states that,”subcutaneous infiltration of cefotaxime 
in clean and clean contaminated cases proved to be very effective in preventing SSI’s” 
Petrakis et all proves single dose ceftriaxone infiltration in high risk cases 
like obesity, carcinoma, diabetic cases, prevented SSI’s drastically. 
They also scientifically proved polk and lopez- meyer’s emphasis that 
wound levels of antibiotic only prevents SSI’s than serum levels. They measured drug 
concentration in serum and wound tissue and drain fluid after iv administration and also 
after local infiltration, and found that adequate tissue levels were achieved for 24 hours 
after surgery with High pressure liquid chromatography method. The concentration 
achieved at local site was much higher than MIC’s of most pathogenic bacteria. 
In our GRH setup, the most common organisms isolated from pus 
culuture report was klebsiella oxytoca, followed by staphylococcus aureus, which both 
are sensitive to ceftriaxone and amikacin. 
Since amikacin could not be infiltrated locally, ceftriaxone was chosen as 
the drug of choice for this study. 
41 
 
Also ceftraixon has a longer half life compared to other third generation 
cephalosporins, effective against obligate anaerobes.    
“The concentration of an appropriate antibiotic in the wound itself, rather 
than in the serum, is the critical factor in determining the efficacy of agents used for the 
prophylaxis of surgical wound infection”. 
Nothing would be accepted scientifically, unless it was proven otherwise. 
To add scientific impact to this study, the concentration of ceftriaxone was measured 
and documented by UV – Spectrophotometric method. 
 
 WHO Model List  – 2003 
           This list contains only 25 essential antibiotics for controlling  most of the surgical 
site infections. 
             For routine use – 19 antibiotics were recommended. 
             For complementary use – 6 have been recommended. 
 
CHOICE OF ANTIBIOTIC 
1. Maintain effective antibiotic level throughout the procedure 
2. Less adverse effects 
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3. Less interference with anaesthetic drugs 
4. Cost effective 
5. Broad spectrum to pathogens 
6. Less interference with host defense 
Antibiotics commonly used in the prophylaxis 
1. Penicillins 
2. Flucloxacillin and methicillin  
3. Ampicillin and amoxycillin  
4. Mezlocillin and azlocillin  
5. Cephalosporins 
6. Aminoglycosides 
7. Vancomycin 
8. Imidazoles 
9. Carbapenem 
10. quinolones 
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CEFTRIAXONE: 
It is third generation cephalosporin, longer acting antibiotic. Average 
plasma concentrations of ceftriaxone following a single 1 gm intravenous dose are 
111mcg/ml after 1 hour, 53 mcg/ml after 6 hours and 9 mcg/ml after 24 hours. 
After intramuscular injection, ceftriaxone was completely absorbed, with 
peak concentration reaching 2-3 hours after injection. 
  33% of ceftriaxone, was excreted unchanged in urine and 
the remainder being secreted in bile.  Hence it should be cautiously used in liver failure 
patients. 
Pharmacokinetics of ceftriaxone is not altered in elderly patients or in 
those with renal impairment hence dosage adjustment is not routinely recommended 
within the recommended usage. (2 gm per day). 
Plasma half life of the drug ranges between 6-8 hours 
Aerobic gram-negative microorganisms Aerobic gram-positive microorganisms 
Acinetobacter calcoaceticus  
Enterobacter aerogenes  
Enterobacter cloacae  
Staphylococcus aureus  
Staphylococcus epidermidis  
Streptococcus pneumoniae  
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Escherichia coli  
Haemophilus influenza, parainfluenzae  
Klebsiella oxytoca  
Klebsiella pneumoniae  
Moraxella catarrhalis  
Morganella morganii  
Neisseria gonorrhoeae, meningitides. 
Proteus mirabilis  
Proteus vulgaris  
Serratia marcescens  
 Pseudomonas aeruginosa. 
Streptococcus pyogenes  
Viridans group streptococci 
Anaerobic microorganisms:  
Bacteroides fragilis  
Peptostreptococcus species 
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GOALS OF ANTIBIOTIC THERAPY 
1.  To maintain the maximum concentration of agent  in the serum and also the 
tissues which is more than the MIC (minimal inhibitory concentration) by  3-4 times for 
not less than three quarters of time   during surgery.  
    MIC – The minimum concentration of antibiotic to kill 99% of organisms. 
2.  Use full doses of chosen antibiotic in the DECISIVE period ( The vulnerable 
period during surgery) 
The MIC concentration of ceftriaxone for susceptible microorganisms are  
as follows: 
Microorganism MIC (mcg/mL) 
Escherichia coli 0.03-0.12 
Staphylococcus aureus 1-8* 
Haemophilus influenzae 0.06-0.25 
Neisseria gonorrhoeae 0.004-0.015 
Streptococcus pneumoniae 0.03-0.12 
Pseudomonas aeruginosa 8-32 
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CEFTRIAXONE AS A PROPHYLACTIC AGENT: 
It has been well established that administration of 1gm of ceftriaxone 
prior to surgery has shown to decrease the occurrence of postoperative infection 
significantly in contaminated or potentially contaminated surgery. Ceftriaxone has been 
shown to effectively control SSI when compared to cefaazolin. The antibiotic effect of 
cephalosporin remains through the surgical procedure and in the postoperative period. 
 Third generation cephalosporins 
 Active against both gram positive and gram negative organism 
 Plasma t ½  =  6-8 hours 
Benefits of subcutaneous administration of ceftriaxone 
1. High and sustained concentration at the site of infection 
2. Limited potential for absorption into systemic circulation and toxicity. 
3. Decrease volume of ceftriaxone use. 
4. Least chance of development of resistance  
5. No first pass metabolism. 
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Disadvantages : 
1. Local hypersensitivity 
2. Dermatitis 
3. Interferes with wound healing 
4. Difficulty in accurately determining the dose. 
 
MEASUREMENT OF CEFTRIOXONE CONCENTRATION: 
Several methods have been described across various literature regarding 
measurement of ceftriaxone concentration in human tissue fluid. Petrakis et al 
described ceftriaxone concentration measurement using HPLC method with APEX 
ODS II SU column with UV detection at 273 nm.  
  Any drug to be measured should be compared against a blank sample. 
Pure drug in the form of salt should be diluted with distilled water in various 
concentrations such as 50 mcg/ml, 100 mcg/ml and the absorption at UV wavelength 
are plotted and taken as control.  
  Bryan et al measured ceftriaxone concentration during cardio bypass 
surgery by HPLC protein precipitation with butanol.  
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  Laleh Enayati Ahangar et al devised measurement of ceftriaxone 
concentration with modified magnetic nano particles Ag modified-magnetic 
nanoparticle (Ag-MNPs) coupled with high performance liquid chromatography 
(HPLC) 
  Shymal kukar et in a study assayed ceftriaxone concentration using 
computerized doublebeam UV-VIS spectrophotometry. By the same ceftriaxone 
showed absorbance at 272 nm wavelength when compared with a blank plasma 
collected at 0 hour. The absorbance of urine supernatant was read at 260 nm for 
ceftriaxone against a blank prepared with urine collected at 0 hour. 
   In a mini review released by American society of microbiology,” An 
ion-pairing (hexadecyltrimethylammonium) RP-HPLC method was reported for 
analyzing ceftriaxone in plasma, urine, and bile” 
  We developed a cheap and easy available and reproducible novel 
method of determining ceftriaxone concentration by computerized UV- visual double 
beam spectrophotometer. Pure drug was dissolved in distilled water at 25 parts per 
million. One ppm is equivalent to 1 milligram of ceftriaxone per liter of water (mg/l). 
the dissolved drug was subjected to UV spectrophotometer and double absorbance 
was observed at 240 and 270 nm respectively. 
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PRINCIPLE BEHIND UV SPECTROPHOTOMETRY: 
‘UV/Vis spectroscopy is used in analytical chemistry for 
the quantitative determination of different analytes, such as transition metal ions, 
highly conjugated organic compounds, and biological macromolecules’. 
The light from the source is ranging from 200 – 800 nm. Normal single 
lamp cannot produce the entire spectrum and hence dual source – one with deuterium 
and other halogen lamp are used. The combined output of these two bulbs get 
focussed on to a diffraction grating slit. This diffraction grating acts akin a prism and 
splits the light into various wavelengths. 
Only desired frequency of narrow wavelength is allowed through the 
slit. 
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 NARROW SPECTRUM AGENTS 
• Gram positive agents include: 
    Penicillin 
    Cloxacillin  
    Erythromycin 
    Clindamycin  
    Vancomycin  
 
 
 
 
Solvent – D. D Water 
Con. Of the compounds- ≈25ppm 
CEFTRIAXONE-UV-vis Spectra 
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Only these wavelengths pass on through a rotating disc. Each disc is made up of 
several sections which may be, 
 Transparent 
 Black, and  
 Mirrored. 
 Those passing through the transparent section, will go straight and attack 
the sample cell and get reflected on to another mirror and fall on a second rotating 
disc. Again, this wavelength of light gets reflected from the mirrored section of 
the second disc and get detected by the computer. 
 When light passing through the mirrored section of the first disc, is 
reflected to the reference cell and goes through the transparent section of the 
second disc, it is detected by the computer. 
 Those wavelengths that pass through the black section gets blocked for a 
short time and this allows the computer for correction of errors, if any generated 
by the detector in the absence of light. 
SAMPLE CELL/REFERENCE CELL: 
 They are made up of small rectangular quartz containers. The sample cell 
contains the biological sample of interest and the reference cell contains the pure 
solvent.  
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 The detector converts the light into current. 
 ‘greater the intensity of light, higher the current’. For each wavelength of 
light that pass via spectrometer, their intensity through the reference cell is also 
measured. That is noted as I0 . The intensity of light passing through the sample 
cell is calculated as I.  
 The computer does some calculations and gives the output as absorbance 
A. 
Absorbance (A)= log 10 (I0/I) 
 Absorbance alone is not very good for making comparisons. It depends on two 
major factors,  
o concentration of the solution and  
o the shape of the container – cubical shape or cylindrical shape. 
BEER LEMBERT’S LAW: 
log 10 (I0/I) = εlc, 
where, 
ε – is the molar absorption coefficient 
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l – the length of the solution the light passes through in cms 
c – is the concentration of the solution mol/L 
 on rearranging this equation,  
c = A / εl 
The Beer-Lambert law states that ‘the absorbance of a solution is directly proportional 
to the concentration of the absorbing species in the solution and the path length.’.  
 Hence UV/V spectroscopy is used to determine the concentration of absorber in 
a solution for a fixed path. The absorbance changes in the concentration can determined 
accurately from a calibration curve. 
 
Surveillance 
  standard definitions must be used to define and categorise  SSIs 
 Classification of wound must be done at the end of operation. 
 Operating surgeon must be informed of the type and classification of infection 
 Surveillance of the wound may be required even after the discharge of the patient 
and followed up regularly. 
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• According  to Hospital Surgical Surveillance Programme, Strict CDC definitions 
must be used to classify the wound 
• Most of the  patients are not  admitted to the hospital 
• When discharged in the early post op period, patient must be asked to follow up 
in the outpatient department till 30 days of surgery 
• Periodical reporting of infection rates must be done.   
Postoperative Nosocomial Infections 
 Postoperative Nosocomial Infections include: 
o Respiratory infections 
o Urinary tract infections 
o Surgical site infections and 
o Septic episodes. 
 Nosocomial infections are due to usage of catheters, instrumentation, intra 
venous and intra arterial access (venflons) and central venous pressure lines. 
 UTI is confirmed by demonstrating WBCs or bacteria in routine urine 
examination or  a positive test for leukocyte esterase, or a combination of these 
two. 
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 It is important that urinary catheters be removed as quickly as possible within24 
to 48 hours, as long as they are ambulant. 
 Pneumonia may be due to prolonged mechanical ventilation and is due to 
pathogens common in the hospital atmosphere. 
 Weaning from mechanical ventilation  should be done as soon as possible.. 
 Most patients with intravascular catheter infections are asymptomatic, except for 
an increase in the blood WBC count. 
 Presence of the same organism in the blood cultures of a patient obtained from a 
peripheral site and through the catheter tells the high index of suspicion.  
 severe sepsis or bacteremia due to gram-negative aerobes or fungi necessitates  
catheter removal. 
  Catheter infections due to S. epidermidis can be effectively treated with a 14- 
to 21-day course of an antibiotic 
Post operative wound sepsis 
           Post operative wound sepsis continues to account for 14% of adverse events in 
hospitalized patients 
                Increases Morbidity,  
                Hospital Stay,  
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                Expensive Antibiotic use and  
                Wastage of manpower 
The inability to deliver antibiotics to the under perfused tissue during surgery 
because of vasoconstriction, hypoxia and shock renders systemic post op antibiotics less 
effective 
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MATERIALS AND METHODS 
Source of data: 
          Patients admitted to Govt. Rajaji hospital Madurai from March 2016 to August 
2016  for emergency or elective laparotomy surgeries were included with the consent 
obtained from the hospital ethical committee meeting conducted by the board members. 
Aim of the study 
 To compare the efficacy of preoperative ceftriaxone infiltration at the incision 
site and Intravenous antibiotic administration with Intravenous ceftriaxone only in 
preventing surgical site infection in all laparotomy surgeries taken in elective and 
emergency manner and measuring the drug concentration in serum and incisional 
tissue drain fluid.  
 
Primary Objectives: 
1. To find the efficacy of preoperative ceftriaxone infiltration at the incision 
site with intravenous ceftriaxone in all laparotomy surgeries. 
2. To compare the efficacy of preoperative ceftriaxone infiltration at the 
incision site in elective and emergency surgeries. 
3. To compare the local site drug concentration achieved after intravenous 
administration with intra incisional drug administration. 
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Secondary Objective: 
1. To compare the efficacy of preoperative ceftriaxone infiltration at the 
incision site in feculent contamination and biliary contamination cases. 
2. To compare the efficacy of preoperative ceftriaxone infiltration at the 
incision site in high risk cases and low risk cases. 
3. To find out whether desirable drug concentration is achieved in tissue fluid 
after intravenous administration of the drug. 
Eligibility criteria 
A.Inclusion criteria: 
1. All patients age more than 13 years of both sexes undergoing laparotomy 
surgeries in Govt. Rajaji Hospital, Madurai.  
2. Patients not allergic to ceftriaxone test dose 
3. Patients consented for inclusion in the study according to designated 
proforma. 
4. All surgeries in which GI tract is entered either as elective or emergency. 
        Clean contaminated (Gastric surgery, whipples) 
        Contaminated (Rectal surgeries) 
        Dirty (Perforative peritonitis, pyo peritoneum, blunt and stab injury 
abdomen) 
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B.Exclusion criteria: 
1. Patients allergic to ceftriaxone test dose 
2. Are jaundiced 
3. Patients suffering from Liver failure 
4. Clean cases where no GI tract is being entered 
5. Immunocompromised 
6. Prolonged steroid therapy 
7. Diabetes mellitus 
8. Patients not consented for inclusion in the study according to designated 
proforma 
Materials used: 
1. Patient clinical history and follow up forms 
2. Informed consent forms in tamil language. 
3. Injection ceftriaxone, 10ml distilled water supplied in our hospital. 
4. Microbiology lab requisition form for pus culture and sensitivity. 
5. Centrifuge and preparation of protein free filtrate. 
6. DOUBLE BEAM UV SPECTROPHOTOMETER – for measuring drug 
concentration. 
 
 
 
60 
 
Methodology: 
 All patients age more than 13 years of both sexes admitted in our GRH planning 
for laparotomy incision surgeries either in an emergency setting or in an elective setting 
with informed written consent. Patients will be randomized into two groups by allotting 
random numbers. In study  
Group A : 
Prophylaxis by both systemic and intra-incisional Infiltration of the Antibiotic (1 
gram of Ceftriaxone was administered intravenously and 1 gram of Ceftriaxone diluted 
with 10 ml of distilled water was infiltrated along the site of proposed incision 20 
minutes before incision after induction by the anaesthetist). 
  
Group B : 
A single dose of 1 gram of Ceftriaxone was administered intravenously 20 
minutes before the surgical incision at the time of induction of anesthesia. 
 
Procedure 
The dose of antibiotic used for infiltration was 1 gram of Ceftriaxone dissolved 
in 10 ml of distilled water (whose concentration of ceftriaxone equals to 100mg/ml) was 
infiltrated uniformly around all the margins of the planned incision with a disposable 
syringe and 16 G needle in subcutaneous tissue plane. Wound was closed with syringe 
suction drain insitu. Serum samples and drain fluid were withdrawn from the patient at 
the end of surgery, 6 hrs following surgery and 24 hrs following surgery. The samples 
61 
 
were centrifuged and supernatant plasma separated and protein free filtrate was 
prepared. The protein free filtrate was prepared by agitating 100 microlitre  with chilled 
acetonitrile 0.5ml  and the supernatant was diluted with 3ml of chilled acetonitrile and  
the resultant supernatant protein free fluid was aspirated and subjected for drug 
concentration measurement with  UV-spectrophotometer and the absorption pattern 
obtained from the UV studies were used to calculate drug concentration by Beer- 
lambert law as described earlier and documented. Operation site was covered by 
occlusive dressings for 48 hours for emergency cases, and 72 hours for elective cases, 
when first inspection of the suture site was carried out. The suture site was left open 
thereafter to inspect daily except in patients who developed infection. Surgical site 
infection is assessed by complication like wound discharge, infection and wound 
dehiscence and classified as serous, seropurulent and purulent discharge. Cases where 
surgical site infection was suspected, occlusive dressing was resorted to twice daily 
wound wash with normal saline and betadine. Wound complications were documented 
as per Centers for Disease Control and Prevention (CDC) guidelines 2016. Patients 
developing any discharges from the surgical wound were investigated by pus swabs for 
culture and appropriate antibiotics were administered as per culture & senstivity report. 
Alternate Sutures were removed on 10th Post op day. Complete suture removal on 14th 
post op day. Subsequently, all cases were followed up in the General Surgery Outpatient 
Department (OPD) at weekly intervals for 1 month.  
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OBSERVATION AND RESULTS 
TABLE 1 AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGE 
DISTRIBUTION CASES CONTROLS 
≤ 20 4 8 
21 – 30 8 7 
31 – 40 5 12 
41 – 50 8 15 
51 – 60 6 12 
61 – 70 3 10 
>70 1 1 
 TOTAL 35 65 
≤ 20 21 – 30 31 – 40 41 – 50 51 – 60 61 – 70 >70
CASES 4 8 5 8 6 3 1
CONTROLS 8 7 12 15 12 10 1
0
2
4
6
8
10
12
14
16
AGE DISTRIBUTION
CASES CONTROLS
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TABLE 2 GENDER DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
MALE : FEMALE RATIO = 2.7 : 1. MALES ARE BEING OPERATED AT HIGHER 
NUMBER THAN FEMALES. 
 
 
 
SEX 
DISTRIBUTION MALES FEMALES 
CASES 28 7 
CONTROLS 45 20 
TOTAL 73 27 
CASES CONTROLS TOTAL
MALES 28 45 73
FEMALES 7 20 27
28
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TABLE 3 INFILTRATION VS INFECTION CONTINGENCY TABLE 
 
INFILTRATION Vs INFECTION 
 INFECTION Total 
ABSENT PRESENT 
INFILTRATION 
NO 33 32 65 
YES 27 8 35 
Total 60 40 100 
 
 
 
 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 6.593a 1 .010   
Continuity Correctionb 5.540 1 .019   
Likelihood Ratio 6.880 1 .009   
Fisher's Exact Test    .011 .008 
Linear-by-Linear Association 6.527 1 .011   
N of Valid Cases 100     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 14.00. 
b. Computed only for a 2x2 table 
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TABLE 4: CORRELATION BETWEEN INFILTRATION, INFECTION AND 
COMPLICATION 
 
CORRELATIONS 
 INFILTRATION POSTOP 
INFECTION 
COMPLICATION 
INFILTRATION 
PEARSON CORRELATION 1 -.257** -.109 
SIG. (2-TAILED)  .010 .281 
N 100 100 100 
INFECTION 
PEARSON CORRELATION -.257** 1 .500** 
SIG. (2-TAILED) .010  .000 
N 100 100 100 
COMPLICATION 
PEARSON CORRELATION -.109 .500** 1 
SIG. (2-TAILED) .281 .000  
N 100 100 100 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
THERE IS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN 
WOUND INFILTRATION WITH ANTIBIOTIC AND POST OF WOUND 
INFECTION AT THE LEVEL OF P=0.01. 
THERE IS A SIGNIFICANT POSITIVE CORRELATION BETWEEN POST 
OPERATIVE INFECTION AND OCCURRENCE OF COMPLICATION AT 
THE LEVEL OF P=0.01. 
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TABLE 5: REGRESSION CURVE 
 
 
 
THERE IS A SIGNIFICANT DECREASE IN POST OPERATIVE INFECTION 
AS INFILTRATION INCREASES WHICH IS EVIDENT FROM THE 
DECREASING TREND CURVE 
 
 
ANOVA 
 Sum of 
Squares 
df Mean Square F Sig. 
Regression 1.500 1 1.500 6.918 .010 
Residual 21.250 98 .217   
Total 22.750 99    
The independent variable is postopinfection. 
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TABLE 6: TYPE OF SURGERY VS INFECTION 
          
 
THERE IS A SIGNIFICANT DIFFERENCE IN INFECTION RATE BETWEEN 
THE ELECTIVE AND EMERGENCY SURGERIES (P =0.015 , P < 0.05) IN 
CONTROLS AND NO SIGNIFICANT DIFFERENCE IN CASES. 
 
                                 
CONTROLS 
INFECTION             
TOTAL 
NO INFECTION INFECTION 
SURGERY 
ELECTIVE 18 8 26 
EMERGENCY 15 24 39 
TOTAL 33 32 65 
                                       
CASES 
INFECTION 
 
                   
TOTAL 
NO INFECTION INFECTION 
SURGERY        
ELECTIVE 
 
10 1 11 
EMERGENCY 17 7 24 
 
TOTAL 27 8 35 
 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS 5.909 1 .015 
CASES 1.724 1 .189 
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TABLE 7: TYPE OF SURGERY VS COMPLICATIONS 
          
 
THERE IS A SIGNIFICANT DIFFERENCE IN COMPLICATION RATE 
BETWEEN THE ELECTIVE AND EMERGENCY SURGERIES (P = 0.008 ,    
P < 0.01) IN CONTROLS AND NO SIGNIFICANT DIFFERENCE IN CASES. 
 
                                 
CONTROLS 
COMPLICATIONS             
TOTAL 
NIL PRESENT 
SURGERY 
ELECTIVE 25 1 26 
EMERGENCY 27 12 39 
TOTAL 52 13 65 
                                       
CASES 
COMPLICATIONS 
 
                   
TOTAL 
NIL PRESENT 
SURGERY        
ELECTIVE 
 
11 0 11 
EMERGENCY 20 4 24 
 
TOTAL 31 4 35 
 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS 7.067 1 .008 
CASES 2.070 1 .150 
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TABLE 8: CLASS OF WOUND VS INFECTION    
    
 
 
 
 
 
 
 
 
 
                                 
CONTROLS 
INFECTION             
TOTAL 
NIL PRESENT 
CLASS OF 
WOUND 
CLEAN 
CONTAMINATED 20 5 25 
CONTAMINATED 2 3 5 
DIRTY 11 24 35 
TOTAL 33 32 65 
                                           
CASES 
INFECTION             
TOTAL 
NIL PRESENT 
CLASS OF 
WOUND 
CLEAN 
CONTAMINATED 9 1 10 
CONTAMINATED 4 1 5 
DIRTY 14 6 20 
TOTAL 27 8 35 
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CLASS OF WOUND VS INFECTION  
 
 
 
 
THERE IS A SIGNIFICANT DIFFERENCE IN INFECTION RATE 
DEPENDING ON CLASS OF WOUND (P =0.001 , P < 0.01) IN CONTROLS AND 
NO SIGNIFICANT DIFFERENCE IN CASES. 
 
 
 
 
 
 
 
 
 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS 14.017 2 .001 
CASES 1.539 2 0.463 
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TABLE 9: CLASS OF WOUND VS COMPLICATION   
    
 
 
 
 
 
 
 
 
 
                                 
CONTROLS 
COMPLICATION             
TOTAL 
NIL PRESENT 
CLASS OF 
WOUND 
CLEAN 
CONTAMINATED 23 2 25 
CONTAMINATED 5 0 5 
DIRTY 24 11 35 
TOTAL 52 13 65 
                                           
CASES 
COMPLICATION             
TOTAL 
NIL PRESENT 
CLASS OF 
WOUND 
CLEAN 
CONTAMINATED 10 0 10 
CONTAMINATED 5 0 5 
DIRTY 16 4 20 
TOTAL 31 4 35 
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CLASS OF WOUND VS COMPLICATION  
 
 
 
 
THERE IS A SIGNIFICANT DIFFERENCE IN COMPLICATION RATE 
DEPENDING ON CLASS OF WOUND (P =0.042 , P < 0.05) IN CONTROLS AND 
NO SIGNIFICANT DIFFERENCE IN CASES. 
 
 
 
 
 
 
 
 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS 6.357 2 0.042 
CASES 3.387 2 0.184 
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TABLE 10: TYPE OF INFECTION VS COMPLICATION    
    
 
 
THERE IS VERY HIGH SIGNIFICANT DIFFERENCE BETWEEN TYPE OF 
INFECTION AND COMPLICATION. P < 0.001 
 
 
                                 COMPLICATION             
TOTAL 
NIL PRESENT 
TYPE OF 
INFECTI
ON 
NO INFECTION 59 1 60 
SUPERFICIAL 17 5 22 
DEEP 5 6 11 
ORGAN 2 5 7 
TOTAL 83 17 100 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS 36.196 3 .000 
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TABLE 11: HOURS OF SURGERY VS INFECTION 
 
 
 
 
 
 
     
 
                                          CASES 
INFECTION 
            TOTAL 
NO INFECTION INFECTION 
HOURS OF 
SURGERY 
≤ 2 HRS 9 4 13 
>2  ≤ 4 HRS 12 2 14 
>4  ≤ 6 HRS 4 1 5 
≥6 HRS 2 1 3 
TOTAL 
27 8 35 
 
 
 
                                 CONTROLS INFECTION             TOTAL 
NO INFECTION INFECTION 
HOURS OF 
SURGERY 
≤ 2 HRS 10 13 23 
>2  ≤ 4 HRS 19 16 35 
>4  ≤ 6 HRS 4 3 7 
TOTAL 33 32 65 
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HOURS OF SURGERY VS INFECTION 
 
 
THERE IS NO SIGNIFICANT DIFFERENCE IN BOTH THE GROUPS 
BETWEEN HOURS OF SURGERY AND PRESENCE OF INFECTION. 
 
 
 
 
 
 
 
 
 
 
PEARSON CHI-SQUARE TESTS VALUE DF ASYMP. SIG. (2-SIDED) 
CONTROLS .776 2 .678 
CASES 1.255 3 .740 
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TABLE 12: CORRELATION BETWEEN TYPE OF CONTAMINANTS AND 
OCCURRENCE OF POST OPERATIVE INFECTION AMONG CONTROLS 
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TABLE 13: CORRELATION BETWEEN TYPE OF CONTAMINANTS AND 
OCCURRENCE OF POST OPERATIVE INFECTION AMONG CASES 
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AMONG CONTROLS, THE CONTAMINANTS WHICH 
SIGNIFICANTLY CONTRIBUTE TO THE OCCURRENCE OF POST 
OPERATIVE INFECTION ARE PUS (P=0.01), FECAL CONTAMINATION 
(P=0.05), GANGRENOUS BOWEL (P=0.05). 
 
   AMONG CASES, THE CONTAMINANTS WHICH 
SIGNIFICANTLY CONTRIBUTE TO THE OCCURRENCE OF POST 
OPERATIVE INFECTION IS PUS ALONE (P=0.05). 
 
HENCE INFILTRATION AT THE WOUND SITE AFFORDS 
SIGNIFICANT PROTECTION AGAINST ALL OF THE CONTAMINANTS 
EXCEPT PUS. 
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TABLE 14: CORRELATION BETWEEN TYPE OF CONTAMINANTS AND 
OCCURRENCE OF COMPLICATIONS OF WOUND AMONG CONTROLS 
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TABLE 15: CORRELATION BETWEEN TYPE OF CONTAMINANTS AND 
OCCURRENCE OF COMPLICATIONS OF WOUND AMONG CASES 
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AMONG CONTROLS, THE CONTAMINANTS WHICH 
SIGNIFICANTLY CONTRIBUTE TO THE OCCURRENCE OF POST 
OPERATIVE COMPLICATION ARE TOXIC FLUID (P=0.01), FECAL 
CONTAMINATION (P=0.05), PUS(P=0.05). 
 
   AMONG CASES, THE CONTAMINANTS WHICH 
SIGNIFICANTLY CONTRIBUTE TO THE OCCURRENCE OF POST OP 
COMPLICATION ARE ASCITES (P=0.01) PUS (P=0.05), TOXIC FLUID 
(P=0.05). 
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ABSORBANCE OF EIGHT DIFFERENT SAMPLES AT 24 HOURS 
 
 
 
 
 
 
 
 
 
 
 
 
UV-Visible studies 
Overlay of Samples from 1-8  
Concentration of the sample : 100µL    Range: 180-600nm 
Peak 1: 214nm    Peak 2: 288nm    Solvent: Acetonitrile 
Measurement is perfect in 100 μL soln. 
100 µL of given solution taken and protein precipitated with 
0. 5 mL of ACN. The then centrifuged. Resulting solution was 
diluted with 3mL of ACN and UV-Vis recorded.   
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ABSORBANCE OF EIGHT DIFFERENT SAMPLES AT END OF SURGERY 
 
 
 
 
UV-Visible studies 
Overlay of Samples from 1-8  
Concentration of the sample : 100µL 
Range: 180-600nm 
Peak 1: 214nm  Peak 2: 288nm Solvent: Acetonitrile 
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CASES 
 
 
 
 
 
 
 
CONTROLS 
 
 
 
 
 
Infiltration cases - mean concentration 
Serum 1 hrs - 102 μG/ml 
Serum end of surgery - 108 μG/ml 
Drain end of surgery - 95 μG/ml 
Serum 6 hrs - 45 μG/ml 
Drain 6 hrs - 20 μG/ml 
Serum 24 hrs - 11.5 μG/ml 
Drain 24 hrs – 4 μG/ml 
Serum end of surgery > Serum 1 hours > Drain 
end of surgery > Serum 6 hrs > Drain 6 hrs >  
Serum 24 hrs > Drain 24 hrs 
Intravenous controls – mean concentration 
Serum 1 hrs - 104 μG/ml 
Serum end of surgery - 90 μG/ml 
Drain end of surgery - 8 μG/ml 
Serum 6 hrs - 39 μG/ml 
Drain 6 hrs - 4 μG/ml 
Serum 24 hrs – 9.5 μG/ml 
Drain 24 hrs – no drug 
Serum 1 hours > Serum end of surgery > Serum 
6 hrs > Serum 24 hrs > Drain end of surgery > 
Drain 6 hrs > Drain 24 hrs. 
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 DISCUSSION AND SUMMARY 
SSI is one of the most commonest complications following surgery.  SSI is 
reportedly the third most commonly reported nosocomial infection and accounts for 14-
16% of all nosocomial infections. Risk of SSI has been described to be around 2.6% in 
all operations and SSI rates are likely to be greater than reported since all surgical 
wounds are contaminated by atmospheric bacteria but only a few actually develop 
clinical infection. A study was carried out in Italy to find out the incidence of SSI in 
general surgery, where 3,066 surgical procedures were carried out in 2,972 patients and 
154 (5%) of them developed SSI. SSI also affects 2.6% of patients undergoing thyroid 
surgery. Bickel studied 210 patients who underwent open surgery for acute appendicitis 
and reported SSI in 5.6% cases. Velezquez studied 80 patients who underwent open 
cholecystectomy and found SSI in 11.25% cases. SSI has been brought down 
considerably by employing various aseptic measures in addition to the use of 
prophylactic systemic antibiotics. However the rate has been static over the past few 
decades. The drawbacks associated with the use of prophylactic systemic antibiotics 
have been lesser concentration of antibiotic at the incision site, fibrin matrix formed at 
the incision site, and improper timing of administration of the antibiotics. 
This prompted newer modes of administering prophylactic antibiotics, one of 
which is the intra-incisional infiltration of the antibiotic to ensure a higher concentration 
of the antibiotic at the incision site. 
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Data from the National Nosocomial Infections Surveillance System reveals that the 
most common SSI pathogens are Staphylococcus aureus, Enterococcus, coagulase 
negative Staphylococcus, Enterobacteriaceae, Pseudomonas species. 
In our study we were able to find out that, 
• Among the 100 patients, 35 of them were cases for whom infiltration was done 
and 65 of them were controls. 
• Among the infiltrated cases, postoperative infection was present in 22% of cases 
(8 cases). 
• Infection was present in approximately 49.23% of patients (32 patients) who 
were controls 
• Among the infected cases, 12% of infection was seen in elective surgery and 
remaining 87.5% of infection following emergency surgery. 
• In controls 25% of the infection occurred following elective surgery and 75% 
were infected following emergency surgery. 
• since most of the patients in our study are taken after emergency surgery, 54% 
of controls(35 patients) and 57.14% of cases (20 patients) were dirty wounds. 
• Since most of them are dirty wound, the incidence of wound infection is also 
high. 
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• Complication rate like wound dehiscence, wound infection, rectus dehiscence, 
burst abdomen observed in 20% of controls (26 patients) and 11.4%(4 patients) 
of cases. 
• This increase in the rate of complication is also because of increased incidence 
of dirty wound. 
• Although duration of surgery has traditionally been inscribed as a component to 
cause infection, there is no significant risk observed in our study. 
• There is high significance between the type of infection and complication . 
• Organ space SSI contributes to 72.42 % of complication and deep SSI to 54.54% 
and superficial SSI 29.41% respectively. 
• On comparing the type of contaminant and occurrence of post operative infection 
among controls, presence of pus is highly significant ( correlation significance 
at the level of 0.01) followed by faecal contamination and presence of 
gangrenous bowel. Among cases only pus is significant ( correlation significant 
at eh level of 0.05) in causing postoperative infection. 
• On comparing the type of contaminant and occurrence of post operative 
complication among controls, presence of toxic fluid is highly significant ( 
correlation significance at the level of 0.01) followed by faecal contamination 
and presence of pus.       Among cases pus, ascites and toxic fluid is significant . 
( correlation significant at eh level of 0.05) in causing postoperative infection. 
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• Among the microorganisms that colonise the postoperative infection, 
staphylococcus accounts for the majority of cases(50%), followed by E.coli 
(31.57%), followed by Klebsiella (15.78%) of cases 
• Among the complications, wound gaping and secondary suturing was needed for 
almost 90 % of the cases, burst abdomen and anastomotic leak constituted for 
5% each.  
Interpretation of drug concentration from this graph 
The graph depicts the absorbance pattern of eight different 
samples. The absorbance pattern was equated in beer lamberts equation and the 
concentration of the drug present in the tissue fluid level separately for the cases 
and controls were calculated. The mean concentration of the drug estimated were 
tabulated separately for cases and controls.  
In cases, the highest concentration of the drug was found in the 
serum at the end of surgery. This could be explained by the subcutaneous 
infiltration of the antibiotic, got absorbed systemically and caused increased 
concentration of the antibiotic at the end of the surgery. But in controls, the 
antibiotic concentration steadily started to decline. The significant change was 
in drain antibiotic concentration immediately after surgery, which is around 10 
times higher than the controls. Though in cases, the mean antibiotic 
concentration was within the MIC of most common organism causing SSI, 
Staphylococcus aureus, Escherichia coli, Haemophilus influenza, Neisseria 
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gonorrhoeae, Streptococcus pneumonia,  there was no drug present at the drain 
site in controls, thereby paving the way for wound infection and its 
complications. 
The concentration of antibiotic in this study adds to the scientific 
impact behind infiltration, that high incisional tissue level of antibiotic for the 
first day prevents post operative infection in a significant manner. 
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SUMMARY 
 Male preponderance was observed in this study 2.7 : 1 
 There is a significant negative correlation  between wound infiltration with 
antibiotic and post of wound infection at the level of p=0.01 evident by the 
declining curve of logistic regression analysis. 
 There is a significant positive correlation between post operative infection and 
occurrence of complication at the level of p=0.01 
 There is a significant difference in infection rate     (p =0.015, p < 0.05) , and 
complication rate (p = 0.008 , p < 0.01) between the elective and emergency 
surgeries in controls and no significant difference in cases. 
 There is a significant difference in infection rate      (p =0.001, p < 0.01), and 
complication rate (p =0.042, p < 0.05) depending on class of wound in controls 
and no significant difference in cases. 
 There is very high significant difference between type of infection (ssi, dsi, osi) 
and complication. P < 0.001. 
 There is no significant difference in both the groups between hours of surgery 
and presence of infection. 
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 Among controls, the contaminants which significantly contribute to the 
occurrence of post operative infection are pus (p=0.01), fecal contamination 
(p=0.05), gangrenous bowel (p=0.05). 
 Among cases, the contaminants which significantly contribute to the occurrence 
of post operative infection is pus alone (p=0.05). 
 Among controls, the contaminants which significantly contribute to the 
occurrence of post operative complication are toxic fluid (p=0.01), fecal 
contamination (p=0.05), pus(p=0.05). 
 Among cases, the contaminants which significantly contribute to the occurrence 
of post op complication are ascites (p=0.01) pus (p=0.05), toxic fluid (p=0.05). 
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CONCLUSION 
In our study there was significant reduction in incidence of SSI in the group, 
which received both Intra incisional and intravenous ceftriaxone preoperatively than the 
other group which received only intravenous ceftriaxone. Preoperative intra incisional 
antibiotics significantly reduces the rate of SSI because of the higher concentration 
achieved at the incision site. 
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PROFORMA 
 
Name   :-      I. P. No  : 
  
Age   :-      Unit        : 
 
Sex   :-      D.O.A     : 
 
Occupation :-      
Address :-      D.O.S     : 
  
Phone no      :      D.O.D     : 
 
 
 
INVESTIGATIONS  
 
1. Blood: Hb %  
2. RBS 
3. RFT 
4. LFT 
5. HBSAG 
6. HCV 
7. HIV 
             
    
DIAGNOSIS  
 
 
 
MANAGEMENT  
 
Pre operative instructions  
 
Type of Anaesthesia  
 
Type of incision  
 
 
DETAILS OF SURGERY 
Date of surgery:     Duration of Surgery(hours): 
Procedure done:      Elective/ Emergency: 
Intra operative findings: 
Intra operative findings present absent remarks 
Fecal contamination   
Ascites  
Biliary contamination   
Pus collection  
Gangrenous bowel   
Hemoperitoneum   
Undigested food particle   
 
 
 
Post-operative instructions  
 
Post-operative period  
 
Post-operative complication management  
 
 
POST OP PUS CULTURE AND SENSITIVITY REPORT 
 
 
 
Concentration of the antibiotic in serum and drain fluid correspondingly 
 
 
 At the end of surgery 6hrs 24 hrs 
Serum    
Drain fluid    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
 
 
ELE – ELECTIVE 
 
EME – EMERGENCY 
 
CONTAMIN – CONTAMINATED WOUND 
 
CLEANCO – CLEAN CONTAMINATED WOUND 
 
Y- YES 
 
N – NO 
 
STAPH – STAPHYLOCOCCUS 
 
E.COLI – ESCHERICHIA COLI 
 
KLEBS – KLEBSIELLA 
 
 
 
 
 
 
 
 
 
 
 
 
 MASTER CHART 
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1 SELVARAJ 50 M 1135444 ELE CA STOMACH CONTAMINATEDDPG+GJ+JJ=FJ Y 4 N N N N N N N N Y N 108 90 45 20 12 3
2 RAJAVALLI 32 F 1071422 EME SIGMOID VOLVULUS CONTAMINATEDHARTMAN'S PROCEDUREY 3 N N Y N N N Y N N Y 110 92 47 22 14 4
3 KAMATCHI 35 F 1071833 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N Y N N N N Y N N 112 98 48 16 13 4
4 KARUTHAKANNAN 65 M 1072344 EME SIGMOID VOLVULUS CONTAMINATEDHARTMAN'S PROCEDUREY 3 N N Y N N N Y N N N 106 96 47 26 12 5
5 KUMAR 30 M 1072415 EME PERFORATIVE PERITONITISDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N N N Y N N N N N 104 95 47 26 10 4
6 MUNIASAMY 30 M 1104477 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2.5 N N N N Y Y N N N Y 106 98 50 18 9 3
7 KUMAR 36 M 1108659 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2 Y SUPERFICIAL SSICONS N N Y Y N N N Y 107 98 43 18 10 3
8 ARJUN 19 M 6513 EME PENETRATING INJURY BULLGORECONTAMINATEDLAPAROTOMY , DRAIN CLOSUREY 3 N N N N N N N Y N N 106 98 42 19 9 2
9 RICHARD ARULSAMY 48 M 1120432 EME MESENTERIC ISCHEMIADIRTY LAPAROTOMY RESECTION AND ILEOSTOMYY 5 Y ORGAN SICITROBACTER Y N N N Y N N Y 107 98 47 26 9 4
10 KARUPPAIAH 50 M 34554 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N N N Y N N N N Y 116 96 48 18 14 4
11 KARUPPAIAH 55 M 1130716 EME OBSTRUCTED INCISIONAL HERNIAC EAN CONTAMINATEDLAPAROTOMY PRIMARY CLOSUREY 2 N N N N N N N N N N 106 95 47 19 11 5
12 RAJU 70 M 1140327 EME INTESTINAL OBSTRUCTIONC TAMINATEDOPEN ADHESIOLYSISY 2 Y SUPERFICIAL SSICONS Y N N N N N N Y 120 102 47 20 8 4
13 VEERAPANDI 40 M 1130784 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N N N Y N N N N Y 115 93 50 26 9 6
14 KATHIRESAN 60 M 1134578 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2.5 N N N N Y N N N Y Y 102 98 43 22 10 3
15 MOOKAMMAL 60 F 1135773 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N N N Y N N N N Y 114 98 42 24 8 4
16 SURIYAPRAKASH 16 M 1135810 EME PERFORATIVE PERITONITIS GASTRIC PERFORATIONDIRTY LAPAROTOMY, PATCH CLOSUREY 2.5 Y D EP SSIKLEBSIELLA YES, WOUND GAPING, ICD INSERTION, SECONDARY SUTURINGN N Y N N N Y Y 106 96 42 24 8 4
17 MURUGAN 30 M 1137112 EME PERFORATIVE PERITONITIS GASTRIC PERFORATIONDIRTY LAPAROTOMY, PATCH CLOSUREY 2 N N N N Y N N N N Y 104 96 41 16 14 3
18 MUTHUKUMAR 29 M 12015 EME PENETRATING INJURY STABDIRTY LAPAROTOMY, GELFOAMY 2 N N N N N N N Y N Y 106 96 47 16 15 5
19 SABARI 17 M 13562 EME PENETRATING IN JURY STABDIRTY LAPAROTOMY, PRIMARY CLOSURE OF GASTRIC WITH STAB SITE CLOSUREY 3 N N N N Y N N Y Y N 107 86 47 18 8 5
20 MARIKUMAR 31 M 124438 EME PENETRATING INJURY - STAB BY FISHDIRTY LAPAROTOMY, WEDGE CLOSURE WITH STAB SITE CLOSUREY 2.5 N N N N Y N N Y Y Y 118 96 50 18 13 4
21 SUBBURAJ 57 M 1139479 EME PERFORATIVE PERITONITIS - SEALEDDIRTY LAPAROTOMY , LAVAGE, DRAIN CLOSUREY 3 Y ORGAN SSINON FERMENTATIVE GR -VE BACILLIYES, N Y N Y N Y N Y 114 86 43 18 8 3
22 MOOKAN 50 M 1139999 EME ACUTE INTESTINAL OBSTRUCTIONDIRTY LAPAROTOMY, L HEMICOLECTOMY, LOOP COLOSTOMY,Y 5 N N YES, Y N N Y Y N N Y 106 98 42 19 12 7
23 RAJAGURU 17 M 1136445 EME SMALL BOWEL ISCHEMIADIRTY LAPAROTOMY, R HEMICOLECTOMY, IT  ANASTOMOSISY 3 N N N N N N N N N N 104 93 50 20 13 3
24 MUTHUKONAR 60 M 57610 ELE ASCENDING COLON STRICTUREDIRTY R HEMICOLECTOMY, IT  ANASTOMOSISY 3 N N N N N N N N N N 106 89 43 20 14 5
25 RAMESH 42 M 1137059 EME APPENDICULAR ABSCESS WITH PERFORATIONDIRTY ABSCESS DRAINAGE WITH APPENDICECTOMYY 1.5 Y SUPERFI IAL SSISTAPHY OCOCCUS N N N Y Y N N N 107 96 42 20 14 4
  
26 PONNUSAMY 70 M 1134592 ELE CA STOMACH CLEAN CONTAMINATEDDPG + ROUX EN Y GJ + JJY 4 N N N N N N N N N N 108 98 47 16 12 4
27 AMBIGA 42 F 49972 ELE CA STOMACH CLEAN CONTAMINATEDDPG + AN COLIC GJY 4.5 N N N N N N N N N Y 106 89 48 16 12 4
28 JEEVARATHINAM 50 F 1130256 ELE CA STOMACH CLEAN CONTAMINATEDDPG + AN COLIC GJ + FJY 4.5 N N N N N N N N Y N 104 93 47 18 14 3
29 MURUGESAN 25 F 1111405 ELE DUODENAL MASS CLEAN CONTAMINATEDWHIPPLE'S PROCEDUREY 6.5 N N N N Y N N N N N 106 98 47 18 14 4
30 KARUPPASAMY 41 M 1110068 ELE CLEAN CONTAMINATEDWHIPPLE'S PROCEDUREY 6.5 Y DEEP SSI.COLI NO N N Y N N N N N 107 100 46 18 11 5
31 PETHI 61 F 14818 ELE CHOLELITHIASIS CLEAN CONTAMINATEDCHOLECYSTECTOMYY 1.5 N N N N Y N N N N N 116 86 46 19 11 3
32 MADURAIVEERAN 23 M 1117178 ELE CA STOMACH CLEAN CONTAMINATEDDPG+GJ+JJ=FJ Y 4 N N Y N N N N N N Y 106 89 42 20 12 6
33 ARUMUGAM 75 M 1119150 ELE CA STOMACH CLEAN CONTAMINATEDDPG+GJ+JJ=FJ Y 5 N N N N N N N N N N 104 93 42 20 12 3
34 VELLAISAMY 46 M 12554 ELE CLEAN CONTAMINATEDWHIPPLE'S PROCEDUREY 6.5 N N N N Y N N N N N 106 98 43 21 11 4
35 VIGNESHWARAN 25 M 8396 EME SELF INFLICT ED PENETRAT ING INJURYDIR Y LAPAROT OMY AND PATCH CLOSUREY 1.5 Y DEEP SSIST APH AUREUSTAB SITE WOUND GAPING, SECONDARY SUTURINGN N Y N Y N Y 116 98 43 21 13 4
36 Dhanapandi 64 M 56411 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROT OMY, PATCH CLOSUREN 2 N N N N Y N N N N N 90 10 36 19 12
37 ALAGAMMAL 70 F 1140241 ELE CARCINOMA RECTUM CLEAN CONTAMINATEDANTERIOR RESECT ION WITH LOOP COLOSTOMYN 4 Y SUPERFICIAL SSIST APHY OCOCCUSgaping, suturingY N N N N N N N 92 8 36 21 12
38 MUTHUPANDI 36 M 56143 ELE CARCINOMA CAECUM DIRTY R HEMICOLECTOMY WITH LOOP ILEOST OMYN 6 Y RGAN S IE.COLI N Y N Y N N N N 98 8 39 22 10
39 VELMURUGAN 28 M 1143371 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROT OMY, PATCH CLOSUREN 2 N N N N Y N N N Y N 96 6 39 4 10
40 BARAT H KUMAR 33 M 58192 EME PERFORATIVE PERITONITIS MULT IPLE ILEALDIRTY RES CTION, IT  ANASTOMOSISN 5 Y ORGAN SSIKLEB ELLA yes, feculent  discharge, gaping Y N N N N N N Y 86 7 43 2 8
41 THEKKAMALAI 35 M 13705 EME PENET RATING INJURY WITH MULTIPLE ILEAL PERFORAT IONWITH ILEAL LACERAT IONDIRTY LA AROT OMY, PRIM RY CLOSURE OF I E L PERFORATION WITH GEL FOAM APPLICATIONN 4 Y DEEP SSI.COL YES, G PING, SU URINGY N N N N Y N Y 89 7 42 2 8
42 NATARAJAN 36 M 1142064 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROT OMY, PATCH CLOSUREN 2 N N N N N N N N N Y 93 8 42 2 9
43 KARUPPASAMY 40 M 1143188 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROT OMY, PATCH CLOSUREN 2 Y SUPERFICIAL SSIST APH N N Y N N N N Y 98 8 41 1 12
44 SARAVANAN 13 M 1132672 ELE CHRONIC MIDGUT VOLVULUSCLEAN CONTAMINATEDLADDS BAND RELEASE WITH DEROTAT IONN 3 N N N N N N N N N N 98 9 34 1 10
45 SIKKANDER 30 M 1127623 EME POST  APPENDICECT OMY ILEAL GANGRENEDIRTY ILEAL R SECT ION AND ANAST OMOSISN 3.5 Y DEEP SINON FERMENTAT IVE GR -VE BACILLIY N N Y Y N N Y 96 9 42 1 10
46 SANKAR 38 M 1126024 EME SMALL BOWEL ISCHEMIADIRTY RESECTION,PRIMARY ANAST OMOSISN 4 Y DEEP SIST APHYLOCOCCUSYES Y N N Y Y N N Y 86 10 42 7 9
47 KAMAT CHI 27 M 109902 EME PERFORATIVE PERITONITIS DUDIRTY LAPAROT OMY, PATCH CLOSUREN 2 Y SUPERFICIAL SSIE.COLI N N N N N N N Y 96 10 42 2 9
48 SUBHA 25 F 1126018 EME ILEOCOLIC INTUSSUSCEPTIONCONTAMINATEDR H MICOLECTOMY WITH IT ANASTOMOSISN 3 Y SUPERFICIAL SIKLEBS E LA N N N N Y N N N 86 12 41 4 10
49 ANANDAKUMAR 29 M 124443 EME BLUNT INJURY ABDOMEN - PERFORATIVE PERIT ONIT ISDIRTY JEJUNAL WEDGE RESECTION AND ANASTOMOSISN 2 Y SUPERFICIAL SSIST APHY OCOCCUSYES, WOUND GAPING, SUTURING DONEY N N N N N N Y 89 12 47 4 9
50 BALASUBRAMANIAM 60 M 1107520 EME RUPT URED LIVER ABSCESSDIRTY LAPAROT OMY AND DRAINAGEN 2 Y ORGAN SSIE COLI RIGHT  ICD INSERTIONN N N Y N N N N 93 6 47 4 8
51 PARAMESHWARAN 64 M 1104209 ELE CA STOMACH CLEAN CONTAMINATEDPALLIATIV  AGJ+FJN 3 N N N Y N N N N N N 96 6 34 6 9
52 RAJAMANI 76 M 1105508 ELE PERIAMPULLARY CA CLEAN CONTAMINATEDTRIPLE BYPASS N 4 N N N Y Y N N N N N 86 8 43 6 9
53 KARUPPAYEE 56 F 1108613 EME CA STOMACH WIT H GAST RIC PERFORATIONDI TY PATCH REPAIR WIT H AGJN 3 Y SUPERFICIAL SSIST APHY OCOCCUS AUREUSYES WOUND GAPING & SECONDARY SUTURINGN N N N N Y Y Y 89 8 42 5 10
54 YAGAPPAN 50 M 1152309 EME ACUTE INT ESTINAL OBST RUCTIONCLEAN C TAMINATEDLAPAROT OMY AND BAND RELEASEN 4 N N N N N N N N N Y 93 6 42 5 10
55 BABU 39 M 1152400 EME POST  LAPAROTOMY BURST  ABDOMENDIRTY RELAPAROTOMY WITH T ENSION BAND WIRINGN 3 Y DEEP SSIKLEBSIELLA Y N N Y N N Y N 96 8 41 4 9
56 MUTHUKARUPPU 65 M 1108426 ELE CA STOMACH CLEAN CONTAMINATEDSUBTOT L GAST RECTOMY WITH ROUX EN Y GJN 4 N N NO N N N N N N Y N 86 8 47 4 9
57 RAJAMANI 65 M 1112767 ELE CA STOMACH CLEAN CONTAMINATEDDPG+BILLROTH 2 ANASTAMOSISN 3.5 N N N N N N N N Y N 89 9 47 5 12
58 THANGAVEL 40 M 1117054 ELE CA RECTUM WIT H LIVER METSCLEAN CONTAMINATEDPROX M L DIVERSION COLOST OMYN 4 N N Y Y N N N N N N 93 9 34 4 9
59 BARAT HIDASAN 46 M 1117096 ELE BILIARY PERTONITIS CONTAMINATEDLAPAROT OMY AND PRIMARY CLOSURE OF ILEUMN 2.5 Y SUPERFICIAL SSIST APHY OCOCCUS N Y Y N N N N Y 89 8 43 3 10
60 JAYARAJ 52 M 1131606 ELE CA HEAD OF PANCREASCLEAN CONTAMINATEDWHIPPLE'S PROCEDUREN 6 N N N N Y N N N N N 96 8 42 2 9
                       
61 RAJAMMAL 60 F 1130509 ELE RIGHT  ILIAC FOSSA MASSCLEAN CONTAMINATEDLAPAROTOMY  AND DEBULKING OF TUMOR WITH ILEOTRANSVERSE ANAST OMOSIS5 Y DEEP SSIKLEBSIELLA Y Y N N N N N 86 9 50 1 8
62 SUBBAMMAL 55 F 1134616 ELE HEPATIC FLEXURE GROWTHCLEAN CONTAMINATEDRIGHT  HEMICOLECTOMY WITH ILEOT RANSVERSE ANASTOMOSISN 4.5 N N NO N N N N N N N N 89 9 43 1 12
63 PANDIYAMMAL 62 F 1133269 ELE CA STOMACH CLEAN CONTAMINATEDSUBTOT L GASTRECTOMY WITH ROUX EN Y GJN 4 N N N N N N N N Y N 93 10 34 1 9
64 SEBASTIAN 67 M 1104765 ELE HYDATID CYST  LIVER CLEAN CONTAMINATEDCYSTOPERICYSTECTOMYN 3 N N N N N N N N N N 98 10 43 7 10
65 NAGESHWARI 50 F 1101962 ELE CA GALL BLADDER CONTAMINATEDCOMPLET ION RADICAL CHOLECYST ECT OMYN 3 Y SUPERFICIAL SSICONS N N Y N N N N N 98 9 42 2 8
66 CHANDRA 40 F 1105350 ELE CA ESOPHAGUS CLEAN CONTAMINATEDTR NSHIATAL ESOPHAGECT OMYN 4.5 N N N N N N N N N N 96 9 42 4 9
67 VADAMUGAM 60 M 1103064 ELE CA ESOPHAGUS CLEAN CONTAMINATEDTR NSHIATAL ESOPHAGECT OMYN 4 Y SUPERFICIAL SSISTAPHY OCOCCUS N N N N N N N N 86 10 41 4 8
68 CHINNAKARUPPU 14 M 7109 ELE CHRONIC CALCIFIC PANCRAT ITISCLEAN CONTAMINATEDFREY'S PROCEDUREN 3.5 N N N N N N N N N N 96 9 47 1 12
69 JEBARAJ 53 M 1109666 ELE PORT  SIT E ADENOCARCINOMA AFTER LAP CHOLECYST ECT OMYDIRTY RADIC L N 3.5 Y DEEP SSI.COLI N N Y Y N N N N 86 12 34 7 9
70 MANIBALAN 15 M 1100418 ELE ADULT  HIRSCHPRUNGS DISEASE POST COLOST OMYCLEAN CONTAMINATEDCOLOANAL PULLT HROUGHN 5 N N Y N N N N N N N 89 9 34 4 10
71 PAKKIRI 46 M 1131490 ELE CBD STRICTURE CLEAN CONTAMINATEDROUX EN Y HEPAT ICOJEJUNOST OMYN 3.5 N N N Y N N N N N 93 6 43 4 10
72 BOOPAT HI 45 F 1136077 ELE CA HEPATIC FLEXURE GROWTHCONTAMINATEDEXT ENDED RIGHT  HEMICOLECT OMYN 3 N N NO Y N N N N N N N 96 9 36 5 9
73 MURUGAN 56 M 57533 EME ACUTE INT EST INAL OBSTRUCTIONDIRTY RESECT ION ANAST OMOSISN 3 Y SUPERFICIAL SSISTAPHY OCOCCUS AUREUSYES; WOUND GAPING; SECONDARY SUTURINGY N N N Y N N Y 86 10 34 4 9
74 ANDIYAPPAN 50 M 1136145 EME SIGMOID VOLVULUS DIRTY HARTMAN'S PROCEDUREN 2.5 Y SUPERFICIAL SSIE COLI Y N N N Y N N Y 89 9 43 3 8
75 BOOMADEVI 60 F 1136198 ELE GALLSTONE DISEASE + CBD STONELEAN CONTAMINATEDCHOLECYST ECT OMY + CBD EXPLORATIONN 2.5 Y DEEP SSI.COL YES; BURST  ABDOMEN-RECTUS SECONDARY SUT URINGN N Y N N N N N 98 10 42 3 9
76 GOVINDARAJ 18 M 1134784 EME BLUNT INJURY ABDOMEN - PERFORAT IVE PERITONIT ISDIRTY PRIMARY CLOSUREN 2 Y DEEP SSISTAPHYLOCOOCUSYES; WOUND GAPING SECONDARY SUTURINGY N N N N N Y Y 98 9 47 7 10
77 MANJULA 45 F 1137185 ELE CHRONIC CALCIFIC PANCRAT ITISCLEAN CONTAMINATEDFREY'S PROCEDUREN 4 N N N N Y N N N N N 96 9 48 4 10
78 JENCY REKHA 23 F 1137343 ELE SPLENOMEGALY WITH HYPERSPLENISMCLEAN CONTA INATEDSPLENECT OMY N 2 N N N N N N N N N N 86 6 38 4 9
79 GANDHI 65 F 1137150 ELE ASCENDING COLON GROWT HCLEAN CONTAMINATEDRIGHT  HEMICOLECTOMY WITH ILEOT RANSVERSE ANASTOMOSISN 3 N N NO NO N N N N N N N N 96 8 37 5 9
80 CHITRA 40 F 1112817 EME DU PERFORATION DIRTY LAPAROTOMY PAT CH CLOSUREN 2 Y SUPERFICIAL SSISTAPH UREUSNO N N Y N N N N Y 86 8 36 4 9
81 VARNAPANDI 58 M 1114294 EME DU PERFORATION DIRTY LAPAROTOMY PAT CH CLOSUREN 2 Y SUPERFICIAL SSI N N Y N N N N Y 89 9 36 2 10
82 SAT HYA 33 F 1124609 EME RUPT URED APPENDIX WITH PELIVC ABSCESSDIRTY LAPAROTOMY AND DRAINAGEN 2 Y ORGAN SSIKLEB ELLA YES; WOUND GAPING; SKIN SECONDARY SUTURINGN N N Y Y N Y 93 8 39 3 10
83 MEENA 67 F 1127276 EME IRREDUCIBLE UMBILICAL HERNIAC EAN CONTAMINATEDLAPAROTOMY AND REDUCT IONN 2.5 N N N N N N N N N N 96 8 39 3 9
84 KARUPPI 55 F 1122454 EME GB PERFORATION DIRTY SUBTOTAL CHOLECYST ECT OMYN 2.5 Y SUPERFICIAL SSISTAPH UREUSNO N N Y N Y N N N 86 8 40 2 9
85 SEENIVASAN 54 M 50061 EME ILEAL STRICTURE WIT H ILEAL PERFORATIONDIRTY ILEAL RESECTION AND ANASTOMOSISN 3 Y SUPERFICIAL SSIE.COLI Y N N N Y N N Y 89 6 40 3 9
86 VALLIRAJA 48 M 1136881 EME CA COLON WITH SUBACUTE INT EST INAL OBSTRUCTIONDIRTY HARTMAN'  PROCEDUREN 2.5 N N N Y N N N N N N 86 7 40 3 9
87 T HAVASI 50 M 1137241 EME STRANGUALATED INCISIONAL HERNIAC TAMINATEDLAPAROTOMY AND PRIMARY CLOSUREN 2 N N N N N N N N N N 89 8 34 2 10
88 KARPAGAM 24 F 1140174 EME APPENDICULAR ABSCESS WITH PERFORATIONDIRTY LAPAROTOMY AND DRAINAGEN 2 Y SUPERFICIAL SSISTAPH UREUSYES; WOUND GAPING; SKIN SECONDARY SUTURINGN N N Y N N Y 93 7 34 2 10
89 HARIHARAN 16 M 1140203 EME PERFORATION PERIT ONITISDIRTY LAPAROTOMY AND PAT CH CLOSUREN 2 N N N N Y N N N N Y 108 8 36 2 9
90 KANNAN 45 M 6328 EME STAB INJURY DIRTY LAPAROTOMY AND PAT CH CLOSUREN 1.5 Y SUPE FICIAL SSISTAPH NO N N N N N Y N Y 98 9 42 2 9
91 NAREN 42 M 9816 EME BLUNT INJURY ABDOMEN - PERFORAT IVE PERITONIT ISCLEAN CONTAMINATEDL PAROTOMY N 2 Y ORGAN SSIE.COLI YES, ANASTOMOT IC LEAKAGEY N N N N Y N Y 96 9 34 4 8
92 VIJENDRAN 19 M 9915 EME BLUNT INJURY ABDOMENCLEAN CONTAMINATEDLAPAROTOMY N 2 N N N N N N N Y N N 86 9 43 4 9
93 MARUT HUPANDI 21 M 11805 EME PENETRATING INJURY ABDOMENDIRTY LAPAROTOMY N 2 N N N N N N N Y N N 78 9 34 5 9
94 MUT HUESWARI 45 F 7416 EME STAB INJURY DIRTY LAPAROTOMY AND PRIMARY CLOSUREN 2.5 Y SUPERFICIAL SSISTAPHY OCOCCUSNO N N N N N Y Y N 100 7 36 4 10
95 KANNAN 41 M 12410 EME BLUNT INJURY ABDOMENDIRTY LAPAROTOMY AND OPEN SPCN 3 N N N N N N N Y N N 98 7 36 4 9
96 MURUGANANTHAM 45 M 45693 EME PERFORATIVE PERIT ONITISDIRTY LAPAROTOMY N 2 N N N N Y N N N N Y 96 6 39 4 9
97 SEETHALAKSHMI 46 F 11664 EME PENETRATING INJURY ABDOMENDIRTY LAPAROTOMY , PRIMARY CLOSUREN 2 N N Y N N N N Y N Y 78 8 35 5 10
98 CHINNATHAMBI 67 M 6312 EME BLUNT INJURY ABDOMENDIRTY LAPAROTOMY, PRIMARY CLOSUREN 2 Y P RFICIAL SSINO NO Y N N N N Y N N 76 9 34 2 12
99 MANIVEL 45 M 7138 EME STAB INJURY ABDOMENDIRTY LAPAROTOMY N 2.5 N N N N N N N Y N N 98 7 43 3 12
100 KASIRAJAN 18 M 9840 EME BLUNT INJURY ABDOMENDIRTY LAPROT OMY, PRIMARY CLOSUREN 2 N N Y N N N N N N Y 98 7 34 3 10
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